EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Mise à jour : Il y a 4 ans
Référence : NCT00647192

Femme et Homme

Extrait

The purpose of this study is to determine whether Eplerenone reduces atrial fibrillation (AF) recurrences within the first 8 weeks after electrical cardioversion of persistent AF.


Critère d'inclusion

  • Atrial fibrillation

Liens